GROW WITH US

Investing in the Future of Clinical Intelligence

Healthcare systems across Europe are undergoing one of the most significant transformations in decades. Rising demand for care, increasing workforce shortages, escalating healthcare expenditure, and the growing prevalence of mental health conditions are placing unprecedented pressure on primary care. At the same time, advances in artificial intelligence, digital health regulation, and interoperability standards are creating new opportunities to fundamentally redesign how care is delivered.

UIZ.CARE has been built to address this transition.

Rather than developing another standalone digital health application, UIZ.CARE is building a clinical intelligence infrastructure platform that enables healthcare professionals to identify health risks earlier, structure clinical decision-making, improve patient engagement, coordinate multidisciplinary care, and support the gradual transition from reactive healthcare toward predictive and preventive medicine.

Youth mental health represents the company's initial clinical application. However, the underlying technology, clinical architecture, and regulatory framework have been designed to support future expansion across multiple areas of healthcare where longitudinal monitoring, clinical decision support, and intelligent care coordination can improve both patient outcomes and healthcare efficiency.

Why UIZ.CARE Is Investable Today

Healthcare innovation is inherently complex. Success depends not only on technology but also on regulatory readiness, clinical validation, workflow integration, interoperability, and institutional trust.

Over the past several years, UIZ.CARE has systematically reduced many of the highest-risk barriers associated with bringing regulated healthcare technology to market.

The platform has progressed beyond concept development through ethics-approved pilot deployment, product refinement, interoperability development, workflow testing with healthcare professionals, implementation learning, and the establishment of a structured quality and regulatory foundation. These activities have generated valuable real-world insights that now inform the company's clinical validation, commercialization, and regulatory strategy.

As a result, the current financing round is intended primarily to accelerate growth rather than fund early-stage experimentation.

Capital will support activities that increase enterprise value through regulatory progression, clinical evidence generation, market access, commercial deployment, and international expansion.

A Large and Growing Market Opportunity

Primary care increasingly serves as the entry point for complex emotional, behavioural, and psychosocial conditions. Young people frequently experience delayed recognition of mental health concerns, fragmented care pathways, and limited continuity between healthcare providers. Simultaneously, clinicians face increasing administrative burden and limited consultation time while managing progressively more complex patient needs.

These structural challenges are driving demand for clinical infrastructure that enables earlier recognition, more structured assessment, improved care coordination, and better allocation of healthcare resources.

The opportunity extends well beyond youth mental health.

The same clinical intelligence infrastructure can support broader healthcare domains where continuous monitoring, patient engagement, AI-assisted decision support, and interoperable care pathways improve efficiency and quality of care across healthcare systems.

Built for Healthcare Systems, Not Consumer Apps

UIZ.CARE has been designed around the realities of clinical practice.

Its platform architecture integrates patient engagement, clinician decision support, interoperability, explainable artificial intelligence, longitudinal health monitoring, and regulatory-grade governance within a single ecosystem.

Rather than relying solely on direct-to-consumer adoption, the company's commercialization strategy focuses on healthcare providers, primary care networks, insurers, public health organisations, and institutional partners that benefit directly from improved clinical workflows, earlier intervention, and more efficient resource allocation.

This creates a business model aligned with long-term healthcare transformation rather than short-term consumer acquisition.

Strong Foundations Reduce Execution Risk

Many digital health companies seek investment while still validating whether their technology can integrate into clinical practice.

UIIZ.CARE has already completed a significant portion of this foundational work.

The platform has been developed through continuous collaboration with healthcare professionals and young people, supported by pilot implementation, usability evaluation, regulatory preparation, interoperability development, and structured product refinement.

This foundation substantially reduces technical and implementation uncertainty while positioning the company for the next phase of value creation.

Future enterprise value is expected to be driven by:

  • MDR regulatory progression;

  • EU AI Act compliance and governance;

  • Clinical validation and evidence generation;

  • Institutional customer acquisition;

  • Reimbursement readiness;

  • Expansion into the Dutch and German healthcare markets;

  • Growth of recurring software revenues;

  • Development of proprietary longitudinal healthcare datasets.

Sustainable Competitive Advantage

Artificial intelligence alone is unlikely to create durable competitive advantage.

UIZ.CARE's long-term defensibility is expected to emerge from the interaction of multiple strategic assets developed over time.

These include:

  • Clinical workflow integration;

  • Longitudinal real-world healthcare data;

  • Explainable clinical AI;

  • Interoperability infrastructure;

  • Regulatory documentation and quality systems;

  • Clinical evidence generation;

  • Institutional partnerships;

  • Healthcare provider trust;

  • Continuous product learning through real-world implementation.

Each successful deployment strengthens the platform while increasing barriers to replication for future competitors.

A Capital-Efficient Growth Strategy

Much of the company's early development has already been supported through founder investment, public innovation programmes, strategic collaborations, pilot projects, and partnerships with healthcare stakeholders.

This allows new investment to focus on accelerating commercialization and regulatory progression rather than rebuilding core technology.

The current financing round will primarily support:

  • MDR regulatory activities and quality management;

  • Clinical studies and evidence generation;

  • EU AI Act implementation;

  • Platform scalability and interoperability;

  • Commercial deployment across the Netherlands;

  • Preparation for expansion into Germany and additional European healthcare markets.

This disciplined allocation of capital is intended to maximise enterprise value while reducing execution risk throughout the next stage of growth.

Why Now

Several structural trends are converging simultaneously.

Healthcare systems increasingly require solutions that improve efficiency without increasing workforce pressure. Governments are investing heavily in digital transformation, artificial intelligence is becoming clinically deployable, interoperability standards continue to mature, and new European regulatory frameworks are establishing higher barriers to entry for future competitors.

Companies capable of combining regulatory readiness, clinical credibility, workflow integration, and scalable technology are well positioned to benefit from this transition.

UIZ.CARE has been intentionally developed to align with these long-term structural shifts.

Investment Thesis

UIZ.CARE is entering a pivotal stage of development where additional capital can unlock disproportionate enterprise value.

The company's highest-risk foundational activities have largely been completed. The next phase focuses on regulatory progression, clinical evidence generation, reimbursement readiness, institutional adoption, and international expansion.

Rather than investing in an early-stage application, investors have the opportunity to support the development of a clinical intelligence infrastructure platform designed to become an integral component of next-generation primary care.

Youth mental health is the initial point of entry. The long-term vision is considerably broader: enabling healthcare systems to detect health risks earlier, support clinicians with trustworthy artificial intelligence, coordinate care more effectively, and build a more predictive, preventive, and patient-centred model of healthcare.

As healthcare increasingly shifts toward intelligent, connected, and data-driven care delivery, UIZ.CARE aims to provide the infrastructure that helps make that transformation possible.

ACCESS THE DATA ROOM